What does CUSIP 23255M105 represent in this 13F holders report?

CUSIP 23255M105 is the security identifier for CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in Q2 2019?

93 institutional investors reported CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK for Q2 2019. Use the holders table for investor-level position and value details.

CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / COMMON STOCK
Shares outstanding: 4,330,313
Total 13F shares: 19,469,585
Share change: +18,613,008
Total reported value: $222,922,553
Price per share: $11.45
Number of holders: 93
Value change: +$213,114,445
Number of buys: 91
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 23255M105?
CUSIP 23255M105 identifies CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 23255M105:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

Top shareholders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	19%	844,085	$12,500,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.25%	10,674	$165,000	—	31 Mar 2019	13F
CWM, LLC	13F	Company	0.01%	297	$1,000	—	31 Mar 2019	13F

Institutional Holders of CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) as of Q2 2019

As of 30 Jun 2019, CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,469,585 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Camber Capital Management LP, MFN Partners Management, LP, BlackRock Inc., Artal Group S.A., VANGUARD GROUP INC, BRIDGER MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and EcoR1 Capital, LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.